Finance

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM ® 3T Laser Therapy System By Investing.com

Newly Launched Technology Will Be on Display at ASSFN in Nashville from June 1 - 4 SOLANA BEACH, Calif., June 01, 2024 (GLOBE NEWSWIRE)...

Self-made millionaire early retirees share biggest money regrets

Early retirees often have plenty of reasons to gloat about their financial prowess.Generally, to call it quits in your 30s or 40s, you...

Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting By Investing.com

NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the Company or Y-mAbs) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on...

NOAA expects 4 to 7 major hurricanes in 2024. How to prepare your home

Hurricane Irma strikes Miami, Florida, in 2017.Warren Faidley | Getty ImagesHurricane season has officially begun.With scientists predicting yet another active year for storms,...

Netanyahu says no Gaza ceasefire until Hamas destroyed By Reuters

By Dan Williams JERUSALEM (Reuters) - Israeli Prime Minister Benjamin Netanyahu said on Saturday there could be no permanent ceasefire in Gaza...

Utilities offer AI exposure, hedge against slowing economy, Goldman says

Utility stocks are an affordable way to gain exposure to the artificial intelligence trend and hedge against a slowing economy even after the...

Delta Air Lines committed to Boeing MAX 10, doesn’t expect delivery soon By Reuters

By Lisa Barrington DUBAI (Reuters) - Delta Air Lines (NYSE:) is still committed to the Boeing (NYSE:) 737 MAX 10 model that...

Software stocks got pummeled this week on troubling earnings reports

Salesforce executives told investors that deals are shrinking or getting delayed. Dell said its margin is getting smaller. Okta highlighted macroeconomic challenges. And...

Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting By Investing.com

NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the Company or Y-mAbs) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on...

Latest articles

spot_imgspot_img